Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.39 |
| ▸ | HPGD | P15428 | 6/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 8/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.39 |
| ▸ | GAA | P10253 | 5/20 | 0.39 |
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | SNCA | P37840 | 2/20 | 0.39 |
| ▸ | NSD2 | O96028 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2191872 | 0.76 | PDK2 (0.41) | — | |
| SCHEMBL24728495 | 0.76 | RAD52 (0.37) | RAD52ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL14262737 | 0.73 | RAD52 (0.41) | RAD52ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL14392561 | 0.73 | ALDH1A1 (0.41) | RAD52ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL30041484 | 0.73 | KMT2A (0.46) | ALDH1A1HSD17B10HPGDTSHRCYP3A4 | |
| SCHEMBL21663225 | 0.71 | PARP1 (0.40) | RAD52ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL15159269 | 0.70 | — | — | |
| SCHEMBL31395712 | 0.70 | ALDH1A1 (0.50) | RAD52ALDH1A1HSD17B10HPGDTSHR | |
| SCHEMBL14392692 | 0.70 | PDK2 (0.39) | ALDH1A1HSD17B10CYP3A4MAPTKDM4E | |
| SCHEMBL5594041 | 0.70 | ALDH1A1 (0.38) | RAD52ALDH1A1HSD17B10HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-07 | — | — | US | disclosed |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-08 | — | — | US | disclosed |
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| WO-2022170022-A1 | OXIDATION RESISTANT POLYMERS FOR USE AS ANION EXCHANGE MEMBRANES AND IONOMERS | UNIVERSITY OF DELAWARE (US) | 2022-08-11 | — | — | WO | disclosed |
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
| US-9882145-B2 | Hetero ring compound and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| WO-2007124543-A1 | PROFLUORESCENT NITROXIDE COMPOUNDS | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007124543-A1 | PROFLUORESCENT NITROXIDE COMPOUNDS | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200234-A1 | ORGANIC COMPOUND, AND ELECTRONIC COMPONENT AND ELECTRONIC DEVICE THEREFOR | OR51E2, CYP4F11, OR10J3 | RAD52 3046/4885ALDH1A1 1310/4885HSD17B10 1211/4885 |
| US-11723271-B2 | Organic compound, and electronic component and electronic device therefor | OR51E2, CYP4F11, OR10J3 | RAD52 3046/4885ALDH1A1 1310/4885HSD17B10 1211/4885 |
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | EXOC1, EXOC4, CHRM1 | RAD52 2009/4885ALDH1A1 1115/4885HSD17B10 3103/4885 |
| US-11807616-B2 | Organic compound, and electronic element and electronic device using same | PIEZO1, OR10J3, OR51E2 | RAD52 3555/4885ALDH1A1 434/4885HSD17B10 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.